Solute carriers (SLCs) in cancer.

[1]  L. Fazli,et al.  Inhibition of glutamine uptake regulates mTORC1, glutamine metabolism and cell growth in prostate cancer , 2014, Cancer & Metabolism.

[2]  H. Kroemer,et al.  Transporters in human platelets: physiologic function and impact for pharmacotherapy. , 2012, Blood.

[3]  D. Plas,et al.  IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1. , 2011, Cancer research.

[4]  Dandan Sun,et al.  Role of sodium/hydrogen exchanger isoform 1 in microglial activation and proinflammatory responses in ischemic brains , 2011, Journal of neurochemistry.

[5]  Y. Bae,et al.  H⁺-myo-inositol transporter SLC2A13 as a potential marker for cancer stem cells in an oral squamous cell carcinoma. , 2011, Current cancer drug targets.

[6]  J. Vera,et al.  Hexose transporter GLUT1 harbors several distinct regulatory binding sites for flavones and tyrphostins. , 2011, Biochemistry.

[7]  T. Nakanishi,et al.  Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy. , 2011, Journal of pharmaceutical sciences.

[8]  G. Chang,et al.  NHE1 mediates MDA-MB-231 cells invasion through the regulation of MT1-MMP. , 2011, Experimental cell research.

[9]  Matthew P. Jacobson,et al.  Dysregulated pH: a perfect storm for cancer progression , 2011, Nature Reviews Cancer.

[10]  V. Ganapathy,et al.  SLC6A14 (ATB0,+) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast Cancer* , 2011, The Journal of Biological Chemistry.

[11]  Ute Hofmann,et al.  Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs) , 2011, PloS one.

[12]  Christina Plaisier,et al.  Berberine acutely activates the glucose transport activity of GLUT1. , 2011, Biochimie.

[13]  Fabian Müller,et al.  Influence of Non-Steroidal Anti-Inflammatory Drugs on Organic Anion Transporting Polypeptide (OATP) 1B1- and OATP1B3-Mediated Drug Transport , 2011, Drug Metabolism and Disposition.

[14]  Hans Clevers,et al.  The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. , 2011, Cell stem cell.

[15]  H. Weiss,et al.  MTORC1 and mTORC2 Regulate EMT, Motility and Metastasis of Colorectal Cancer via RHOA and RAC1 Signaling Pathways , 2011 .

[16]  Y. Sasaguri,et al.  Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells , 2011, Cancer science.

[17]  Peeyush Kumar,et al.  Vitamin D3 restores altered cholinergic and insulin receptor expression in the cerebral cortex and muscarinic M3 receptor expression in pancreatic islets of streptozotocin induced diabetic rats. , 2011, The Journal of nutritional biochemistry.

[18]  Chi V. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[19]  H. Weiss,et al.  mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. , 2011, Cancer research.

[20]  Ming-Shiang Wu,et al.  HDAC Inhibition Decreases the Expression of EGFR in Colorectal Cancer Cells , 2011, PloS one.

[21]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[22]  V. Ganapathy,et al.  Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate , 2011, Oncogene.

[23]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[24]  Da-zhi Ke,et al.  Suppression of NHE1 by small interfering RNA inhibits HIF-1α-induced angiogenesis in vitro via modulation of calpain activity. , 2011, Microvascular research.

[25]  De-sheng Wang,et al.  Suppression of Na+/H+ exchanger 1 by RNA interference or amiloride inhibits human hepatoma cell line SMMC-7721 cell invasion , 2011, Medical oncology.

[26]  Albrecht Schwab,et al.  Intracellular pH gradients in migrating cells. , 2011, American journal of physiology. Cell physiology.

[27]  Maria J Perez,et al.  Further Characterization of the Electrogenicity and pH Sensitivity of the Human Organic Anion-Transporting Polypeptides OATP1B1 and OATP1B3 , 2011, Molecular Pharmacology.

[28]  D. Schrama,et al.  B-Raf Associates with and Activates the NHE1 Isoform of the Na+/H+ Exchanger* , 2011, The Journal of Biological Chemistry.

[29]  Matthew T. Haren,et al.  Testosterone modulates gene expression pathways regulating nutrient accumulation, glucose metabolism and protein turnover in mouse skeletal muscle. , 2011, International journal of andrology.

[30]  De-sheng Wang,et al.  Expression and modulation of Na+/H+ exchanger 1 gene in hepatocellular carcinoma: A potential therapeutic target , 2011, Journal of gastroenterology and hepatology.

[31]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[32]  H. Kusuhara,et al.  Prediction of Fluoroquinolone‐Induced Elevation in Serum Creatinine Levels: A Case of Drug–Endogenous Substance Interaction Involving the Inhibition of Renal Secretion , 2011, Clinical pharmacology and therapeutics.

[33]  P. A. Friedman,et al.  Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling , 2010, Oncogene.

[34]  S. Thiagalingam,et al.  Therapeutics , Targets , and Chemical Biology Smad 4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer , 2011 .

[35]  D. Loo,et al.  Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2. , 2011, American journal of physiology. Cell physiology.

[36]  Y. Kaufmann,et al.  Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake , 2011, Cancer Chemotherapy and Pharmacology.

[37]  H. Bönisch,et al.  Oxybutynin and trospium are substrates of the human organic cation transporters , 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.

[38]  H. Glaeser,et al.  Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. , 2010, Biochemical pharmacology.

[39]  N. Sunaga,et al.  Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. , 2010, Anticancer research.

[40]  M. Czeredys,et al.  Regulation of amino acid/carnitine transporter B0,+ (ATB0,+) in astrocytes by protein kinase C: independent effects on raft and non‐raft transporter subpopulations , 2010, Journal of neurochemistry.

[41]  Varsha Singh,et al.  The probiotic Lactobacillus plantarum counteracts TNF-{alpha}-induced downregulation of SMCT1 expression and function. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[42]  E. Delpire,et al.  Deficiency of electroneutral K+–Cl− cotransporter 3 causes a disruption in impulse propagation along peripheral nerves , 2010, Glia.

[43]  H. Naraba,et al.  DNA Damage–Induced Modulation of GLUT3 Expression Is Mediated through p53-Independent Extracellular Signal-Regulated Kinase Signaling in HeLa Cells , 2010, Molecular Cancer Research.

[44]  H. Arakawa,et al.  Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors. , 2010, Biochemical pharmacology.

[45]  J. Nylandsted,et al.  NBCn1 and NHE1 expression and activity in DeltaNErbB2 receptor-expressing MCF-7 breast cancer cells: contributions to pHi regulation and chemotherapy resistance. , 2010, Experimental cell research.

[46]  C. Salaün,et al.  Identification of a Novel Transport-independent Function of PiT1/SLC20A1 in the Regulation of TNF-induced Apoptosis* , 2010, The Journal of Biological Chemistry.

[47]  K. Aldape,et al.  Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation. , 2010, Cancer research.

[48]  M. Fukuzawa,et al.  Cisplatin upregulates glutamine transport in human intestinal epithelial cells: the protective mechanism of glutamine on intestinal mucosa after chemotherapy. , 2010, JPEN. Journal of parenteral and enteral nutrition.

[49]  Yong Li,et al.  Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression , 2010, British Journal of Cancer.

[50]  J. Coon,et al.  LAT1 Regulates Growth of Uterine Leiomyoma Smooth Muscle Cells , 2010, Reproductive Sciences.

[51]  H. Sontheimer,et al.  Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion. , 2010, Cancer research.

[52]  L. Melvin,et al.  Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes. , 2010, Canadian journal of physiology and pharmacology.

[53]  V. Ganapathy,et al.  Sodium-coupled electrogenic transport of pyroglutamate (5-oxoproline) via SLC5A8, a monocarboxylate transporter. , 2010, Biochimica et biophysica acta.

[54]  A. Bado,et al.  Luminal leptin inhibits L-glutamine transport in rat small intestine: involvement of ASCT2 and B0AT1. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[55]  Bert W O'Malley,et al.  Research resource: expression profiling reveals unexpected targets and functions of the human steroid receptor RNA activator (SRA) gene. , 2010, Molecular endocrinology.

[56]  S. Pervaiz,et al.  The fourth isoform of the adenine nucleotide translocator inhibits mitochondrial apoptosis in cancer cells. , 2010, The international journal of biochemistry & cell biology.

[57]  V. Ganapathy,et al.  Diclofenac-induced stimulation of SMCT1 (SLC5A8) in a heterologous expression system: a RPE specific phenomenon. , 2010, Biochemical and biophysical research communications.

[58]  T. Yeatman,et al.  Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. , 2010, Cancer research.

[59]  S. Suh,et al.  Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells , 2010, Anti-cancer drugs.

[60]  R. Franklin,et al.  Ras responsive element binding protein‐1 (RREB‐1) down‐regulates hZIP1 expression in prostate cancer cells , 2010, The Prostate.

[61]  Vedrana Milinkovic,et al.  Identification of genes associated with non-small-cell lung cancer promotion and progression. , 2010, Lung cancer.

[62]  W. Alrefai,et al.  Mechanisms of lysophosphatidic acid (LPA) mediated stimulation of intestinal apical Cl-/OH- exchange. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[63]  W. Alrefai,et al.  Mechanisms of transcriptional modulation of the human anion exchanger SLC26A3 gene expression by IFN-{gamma}. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[64]  Y. Kanai,et al.  l‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth , 2010, Cancer science.

[65]  Z. Fei,et al.  The expression and significance of HIF-1α and GLUT-3 in glioma , 2009, Brain Research.

[66]  R. Moreno-Sánchez,et al.  Kinetics of transport and phosphorylation of glucose in cancer cells , 2009, Journal of cellular physiology.

[67]  M. Salto‐Tellez,et al.  Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo. , 2009, Cancer research.

[68]  D. Mount,et al.  Motor protein-dependent membrane trafficking of KCl cotransporter-4 is important for cancer cell invasion. , 2009, Cancer research.

[69]  V. Ganapathy,et al.  Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3‐bromopyruvate , 2009, Cancer.

[70]  N. Trottier,et al.  Dietary protein intake and stage of lactation differentially modulate amino acid transporter mRNA abundance in porcine mammary tissue. , 2009, The Journal of nutrition.

[71]  Jeffrey M. Rosen,et al.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.

[72]  N. Mohebbi,et al.  The calcineurin inhibitor FK506 (tacrolimus) is associated with transient metabolic acidosis and altered expression of renal acid-base transport proteins. , 2009, American journal of physiology. Renal physiology.

[73]  G. Packham,et al.  Inhibition of hypoxia inducible factor by phenethyl isothiocyanate. , 2009, Biochemical pharmacology.

[74]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[75]  G. Burckhardt,et al.  Ability of sat-1 to transport sulfate, bicarbonate, or oxalate under physiological conditions. , 2009, American journal of physiology. Renal physiology.

[76]  S. Bröer,et al.  Metabolic Effects of Blocking Lactate Transport in Brain Cortical Tissue Slices Using an Inhibitor Specific to MCT1 and MCT2 , 2009, Neurochemical Research.

[77]  J. Whitehead,et al.  Reduced phosphorylation of AS160 contributes to glucocorticoid-mediated inhibition of glucose uptake in human and murine adipocytes , 2009, Molecular and Cellular Endocrinology.

[78]  R. Franklin,et al.  The important role of the apoptotic effects of zinc in the development of cancers , 2009, Journal of cellular biochemistry.

[79]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[80]  C. Sander,et al.  V600EBRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway , 2009, Proceedings of the National Academy of Sciences.

[81]  J. Prehn,et al.  Regulation of Glucose Transporter 3 Surface Expression by the AMP-Activated Protein Kinase Mediates Tolerance to Glutamate Excitation in Neurons , 2009, The Journal of Neuroscience.

[82]  T. Aoki,et al.  Molecular and functional characterization of choline transporter in human colon carcinoma HT-29 cells. , 2009, Archives of biochemistry and biophysics.

[83]  W. Linehan,et al.  LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer , 2009, Molecular Cancer Therapeutics.

[84]  N. Philp,et al.  Interaction of Monocarboxylate Transporter 4 with ␤ 1 -integrin and Its Role in Cell Migration , 2022 .

[85]  S. Grimm,et al.  Isolation of ORCTL3 in a novel genetic screen for tumor-specific apoptosis inducers , 2009, Cell Death and Differentiation.

[86]  M. Dean.  ABC Transporters, Drug Resistance, and Cancer Stem Cells , 2009, Journal of Mammary Gland Biology and Neoplasia.

[87]  G. Burckhardt,et al.  Expression of human organic cation transporter 3 in kidney carcinoma cell lines increases chemosensitivity to melphalan, irinotecan, and vincristine. , 2009, Cancer research.

[88]  Jeffrey P. MacKeigan,et al.  Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.

[89]  O. Ilkayeva,et al.  Glucose metabolism as a target of histone deacetylase inhibitors. , 2009, Molecular endocrinology.

[90]  M. Melchiorre,et al.  Involvement of the p66Shc protein in glucose transport regulation in skeletal muscle myoblasts. , 2009, American journal of physiology. Endocrinology and metabolism.

[91]  M. Wessling-Resnick,et al.  Small molecule inhibitors of divalent metal transporter-1. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[92]  Q. Zhan,et al.  Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway , 2009, Oncogene.

[93]  Y. Tabuchi,et al.  Functional Association between K+-Cl- Cotransporter-4 and H+,K+-ATPase in the Apical Canalicular Membrane of Gastric Parietal Cells* , 2009, Journal of Biological Chemistry.

[94]  V. Ganapathy,et al.  Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. , 2009, Pharmacology & therapeutics.

[95]  A. Rustgi,et al.  Induction of intestinalization in human esophageal keratinocytes is a multistep process. , 2009, Carcinogenesis.

[96]  S. Lam,et al.  The xc− cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine , 2009, Cancer Chemotherapy and Pharmacology.

[97]  J. Dick,et al.  Stem cell concepts renew cancer research. , 2008, Blood.

[98]  T. Herbert,et al.  Inhibition of SNAT2 by metabolic acidosis enhances proteolysis in skeletal muscle. , 2008, Journal of the American Society of Nephrology.

[99]  M. Minden,et al.  A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death , 2008, Molecular Cancer Therapeutics.

[100]  J. Shan,et al.  Despite Increased ATF4 Binding at the C/EBP-ATF Composite Site following Activation of the Unfolded Protein Response, System A Transporter 2 (SNAT2) Transcription Activity Is Repressed in HepG2 Cells* , 2008, Journal of Biological Chemistry.

[101]  D. Munn,et al.  Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy. , 2008, The Biochemical journal.

[102]  Christel A. S. Bergström,et al.  Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. , 2008, Journal of medicinal chemistry.

[103]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[104]  E. Dudenhausen,et al.  Activated transcription via mammalian amino acid response elements does not require enhanced recruitment of the Mediator complex , 2008, Nucleic acids research.

[105]  Guido Kroemer,et al.  Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.

[106]  Y. Kanai,et al.  BCH, an inhibitor of system L amino acid transporters, induces apoptosis in cancer cells. , 2008, Biological & pharmaceutical bulletin.

[107]  Baoman Li,et al.  Astrocytic alkalinization by therapeutically relevant lithium concentrations: implications for myo-inositol depletion , 2008, Psychopharmacology.

[108]  M. Hung,et al.  Survival of cancer cells is maintained by EGFR independent of its kinase activity. , 2008, Cancer cell.

[109]  Quan P. Ly,et al.  Silencing of the Candidate Tumor Suppressor Gene Solute Carrier Family 5 Member 8 (SLC5A8) in Human Pancreatic Cancer , 2008, Pancreas.

[110]  R. Callaghan,et al.  Resistance to Chemotherapy in Cancer: A Complex and Integrated Cellular Response , 2008, Pharmacology.

[111]  D. Conklin,et al.  xCT expression reduces the early cell cycle requirement for calcium signaling. , 2008, Cellular signalling.

[112]  D. Shennan,et al.  Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells. , 2008, Oncology reports.

[113]  T. Sakaeda,et al.  Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines , 2008, Cancer Chemotherapy and Pharmacology.

[114]  H. Sax,et al.  In Human Entrocytes, GLN Transport and ASCT2 Surface Expression Induced by Short-Term EGF are MAPK, PI3K, and Rho-Dependent , 2008, Digestive Diseases and Sciences.

[115]  G. Malnic,et al.  NHE1, NHE2, and NHE4 contribute to regulation of cell pH in T84 colon cancer cells , 2008, Pflügers Archiv - European Journal of Physiology.

[116]  M. Tang,et al.  KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition. , 2007, Cancer research.

[117]  I. Binet,et al.  The Specific Monocarboxylate Transporter (MCT1) Inhibitor, AR-C117977, a Novel Immunosuppressant, Prolongs Allograft Survival in the Mouse , 2007, Transplantation.

[118]  Jun-Mo Yang,et al.  Effect of Cl− on Tyrosinase: Complex Inhibition Kinetics and Biochemical Implication , 2007, Journal of biomolecular structure & dynamics.

[119]  H. Sontheimer,et al.  Autocrine glutamate signaling promotes glioma cell invasion. , 2007, Cancer research.

[120]  Xavier Tekpli,et al.  Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells. , 2007, Cancer research.

[121]  T. Albert,et al.  Normoxic stabilization of HIF-1alpha drives glycolytic metabolism and regulates aggrecan gene expression in nucleus pulposus cells of the rat intervertebral disk. , 2007, American journal of physiology. Cell physiology.

[122]  O. Ishiko,et al.  Expression of glucose transporters in epithelial ovarian carcinoma: correlation with clinical characteristics and tumor angiogenesis. , 2007, Oncology reports.

[123]  Ian O Ellis,et al.  The Emerging Role of the LIV-1 Subfamily of Zinc Transporters in Breast Cancer , 2007, Molecular medicine.

[124]  N. Illsley,et al.  Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1. , 2007, American journal of physiology. Cell physiology.

[125]  Ellen Friday,et al.  Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast cancer-derived cells MDA-MB-231 , 2007, BMC Cancer.

[126]  S. Yung,et al.  Mesothelial Cells , 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[127]  T. Terasaki,et al.  Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 mRNAs with differentiation state of human colon tumor. , 2007, Biological & pharmaceutical bulletin.

[128]  J. Engele,et al.  DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells , 2007, Glia.

[129]  A. Paradiso,et al.  The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. , 2007, Molecular biology of the cell.

[130]  T. Hirano,et al.  Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells , 2007, Cancer science.

[131]  N. Philp,et al.  Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. , 2007, Cancer research.

[132]  D. Sabatini,et al.  Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. , 2007, Blood.

[133]  R. Kim,et al.  Naringin is a Major and Selective Clinical Inhibitor of Organic Anion‐Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice , 2007, Clinical pharmacology and therapeutics.

[134]  S. Nielsen,et al.  Vacuolar H+‐ATPase expression is increased in acid‐secreting intercalated cells in kidneys of rats with hypercalcaemia‐induced alkalosis , 2007, Acta physiologica.

[135]  Wen-ying Lee,et al.  IGF‐1 upregulates electroneutral K‐Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness , 2007, Journal of cellular physiology.

[136]  W. Sadee,et al.  Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia , 2007, Cancer Chemotherapy and Pharmacology.

[137]  Huaqing Zhao,et al.  The H+-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma , 2006, Molecular Pharmacology.

[138]  M. Setou,et al.  Regulation of Amino Acid Transporter ATA2 by Ubiquitin Ligase Nedd4-2* , 2006, Journal of Biological Chemistry.

[139]  K. Kanamori,et al.  Kinetics of glial glutamine efflux and the mechanism of neuronal uptake studied in vivo in mildly hyperammonemic rat brain , 2006, Journal of neurochemistry.

[140]  B. Cannon,et al.  Carboxyatractyloside effects on brown-fat mitochondria imply that the adenine nucleotide translocator isoforms ANT1 and ANT2 may be responsible for basal and fatty-acid-induced uncoupling respectively. , 2006, The Biochemical journal.

[141]  C. Smith,et al.  IGF regulation of neutral amino acid transport in the BeWo choriocarcinoma cell line (b30 clone): evidence for MAP kinase-dependent and MAP kinase-independent mechanisms. , 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[142]  G. Kroemer,et al.  Chemosensitization by knockdown of adenine nucleotide translocase-2. , 2006, Cancer research.

[143]  M. Wessling-Resnick,et al.  Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake. , 2006, Chemistry & biology.

[144]  Ying Huang,et al.  Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells. , 2006, Cancer letters.

[145]  T. M. Zorn,et al.  Increased NHE1 expression is associated with serum deprivation-induced differentiation in immortalized rat proximal tubule cells. , 2006, American journal of physiology. Renal physiology.

[146]  Y. Ohno,et al.  Functional expression of A glutamine transporter responsive to down‐regulation by lipopolysaccharide through reduced promoter activity in cultured rat neocortical astrocytes , 2006, Journal of neuroscience research.

[147]  M. Hatzoglou,et al.  Amino Acid Starvation Induces the SNAT2 Neutral Amino Acid Transporter by a Mechanism That Involves Eukaryotic Initiation Factor 2α Phosphorylation and cap-independent Translation* , 2006, Journal of Biological Chemistry.

[148]  V. Trachana,et al.  Inhibition of the Na+-H+ Exchanger Isoform-1 and the Extracellular Signal-Regulated Kinase Induces Apoptosis: a Time Course of Events , 2006, Cellular Physiology and Biochemistry.

[149]  Dong Hee Lee,et al.  Characterization of taurine as inhibitor of sodium glucose transporter. , 2006, Advances in experimental medicine and biology.

[150]  D. Thakker,et al.  Differential Substrate and Inhibitory Activities of Ranitidine and Famotidine toward Human Organic Cation Transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3) , 2005, Journal of Pharmacology and Experimental Therapeutics.

[151]  J. Mcgivan,et al.  Identification of the promoter elements involved in the stimulation of ASCT2 expression by glutamine availability in HepG2 cells and the probable involvement of FXR/RXR dimers. , 2005, Archives of biochemistry and biophysics.

[152]  P. Soares-da-Silva,et al.  Interferon-γ-induced STAT1-mediated membrane retention of NHE1 and associated proteins ezrin, radixin and moesin in HT-29 cells , 2005 .

[153]  Ying Huang,et al.  Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. , 2005, Cancer research.

[154]  B. Fuchs,et al.  Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? , 2005, Seminars in cancer biology.

[155]  W. Sadee,et al.  ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. , 2005, Cancer research.

[156]  R. Rodnight,et al.  Signal Transduction Mechanisms Involved in the Proliferation of C6 Glioma Cells Induced by Lysophosphatidic Acid , 2005, Neurochemical Research.

[157]  T. Fujita,et al.  Functional regulation of Na+‐dependent neutral amino acid transporter ASCT2 by S‐nitrosothiols and nitric oxide in Caco‐2 cells , 2005, FEBS letters.

[158]  Altered expression of iron transport proteins in streptozotocin-induced diabetic rat kidney. , 2005, Biochimica et biophysica acta.

[159]  S. A. Thomson,et al.  Identification and characterisation of a new class of highly specific and potent inhibitors of the mitochondrial pyruvate carrier. , 2005, Biochimica et biophysica acta.

[160]  P. Soares-da-Silva,et al.  Interferon-gamma-induced STAT1-mediated membrane retention of NHE1 and associated proteins ezrin, radixin and moesin in HT-29 cells. , 2005, Biochemical pharmacology.

[161]  M. Cherian,et al.  Role of p53 and reactive oxygen species in apoptotic response to copper and zinc in epithelial breast cancer cells , 2005, Apoptosis.

[162]  M. Hershfinkel,et al.  Extracellular Zinc Triggers ERK-dependent Activation of Na+/H+ Exchange in Colonocytes Mediated by the Zinc-sensing Receptor* , 2004, Journal of Biological Chemistry.

[163]  M. Tang,et al.  Insulin-like Growth Factor 1 Stimulates KCl Cotransport, Which Is Necessary for Invasion and Proliferation of Cervical Cancer and Ovarian Cancer Cells* , 2004, Journal of Biological Chemistry.

[164]  W. Muller,et al.  Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. , 2004, Cancer cell.

[165]  G. Werther,et al.  Neuronal protection from glucose deprivation via modulation of glucose transport and inhibition of apoptosis: a role for the insulin-like growth factor system , 2004, Brain Research.

[166]  T. Hirano,et al.  Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer , 2004, Nature.

[167]  J. Medina,et al.  Endothelin‐1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: relationship with gap junctional communication , 2004, Journal of neurochemistry.

[168]  Hong Wang,et al.  Platelet‐derived growth factor stimulates LAT1 gene expression in vascular smooth muscle: Role in cell growth , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[169]  L. Landi,et al.  Stem cell factor and H2O2 induce GLUT1 translocation in M07e cells , 2004, BioFactors.

[170]  A. Means,et al.  Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. , 2003, Endocrine reviews.

[171]  H. Uramoto,et al.  Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. , 2003, Cancer treatment reviews.

[172]  R. Nicholson,et al.  Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters. , 2003, The Biochemical journal.

[173]  Xin Lu,et al.  Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. , 2003, Molecular cancer research : MCR.

[174]  C. Plass,et al.  SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[175]  B. Banas,et al.  Regulation of glucose transporters in human peritoneal mesothelial cells. , 2003, Journal of nephrology.

[176]  T. Vary,et al.  Epidermal growth factor activation of intestinal glutamine transport is mediated by mitogen-activated protein kinases , 2003, Journal of Gastrointestinal Surgery.

[177]  H. Koepsell,et al.  The Organic Cation Transporters rOCT1 and hOCT2 Are Inhibited by cGMP , 2002, The Journal of Membrane Biology.

[178]  R. Franklin,et al.  Direct effect of zinc on mitochondrial apoptogenesis in prostate cells , 2002, The Prostate.

[179]  M. K. Byeon,et al.  The colon anion transporter, down-regulated in adenoma, induces growth suppression that is abrogated by E1A. , 2002, Cancer research.

[180]  Gui-jun Huang,et al.  [Effect of co-inhibition of MCT1 gene and NHE1 gene on proliferation and growth of human lung adenocarcinoma cells]. , 2002, Ai zheng = Aizheng = Chinese journal of cancer.

[181]  W. Souba,et al.  Protein kinase C activation of intestinal glutamine transport is mediated by mitogen-activated protein kinases. , 2002, The Journal of surgical research.

[182]  K. Peyrollier,et al.  Insulin Promotes the Cell Surface Recruitment of the SAT2/ATA2 System A Amino Acid Transporter from an Endosomal Compartment in Skeletal Muscle Cells* , 2002, The Journal of Biological Chemistry.

[183]  J. Erickson,et al.  Selective up-regulation of system a transporter mRNA in diabetic liver. , 2002, Biochemical and biophysical research communications.

[184]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[185]  M. Kilberg,et al.  Physiological importance of system A-mediated amino acid transport to rat fetal development. , 2002, American journal of physiology. Cell physiology.

[186]  E. Wright,et al.  Common mechanisms of inhibition for the Na+/glucose (hSGLT1) and Na+/Cl−/GABA (hGAT1) cotransporters , 2001, British journal of pharmacology.

[187]  N. Bruchovsky,et al.  Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc− cystine transporter: a new action for an old drug , 2001, Leukemia.

[188]  M. Ito,et al.  Molecular events involved in up-regulating human Na+-independent neutral amino acid transporter LAT1 during T-cell activation. , 2001, The Biochemical journal.

[189]  J. Vera,et al.  Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors. , 2001, Biochemistry.

[190]  N. Vázquez,et al.  Functional Comparison of the K+-Cl−Cotransporters KCC1 and KCC4* , 2000, The Journal of Biological Chemistry.

[191]  J. Ellory,et al.  Volume-sensitive KCl cotransport associated with human cervical carcinogenesis , 2000, Pflügers Archiv.

[192]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[193]  D. Kang,et al.  Changes of glucose transporters in the cerebral adaptation to hypoglycemia. , 2000, Diabetes research and clinical practice.

[194]  H. Seo,et al.  Expression of E16/CD98LC/hLAT1 is responsive to 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin , 1999, FEBS letters.

[195]  T. Asano,et al.  T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes. , 1999, Diabetes.

[196]  G. Desoye,et al.  Hyperglycemia regulates the glucose‐transport system of clonal choriocarcinoma cells in vitro. A potential molecular mechanism contributing to the adjunct effect of glucose in tumor therapy , 1998, International journal of cancer.

[197]  A. McCall,et al.  Unique mechanism of GLUT3 glucose transporter regulation by prolonged energy demand: increased protein half-life. , 1998, The Biochemical journal.

[198]  S. Vannucci,et al.  Thrombin-induced translocation of GLUT3 glucose transporters in human platelets. , 1997, The Biochemical journal.

[199]  M. Kansara,et al.  Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst. , 1997, The Biochemical journal.

[200]  W. Hiddemann,et al.  Influence of cycloheximide-mediated downregulation of glucose transport on TNF alpha-induced apoptosis. , 1997, Experimental cell research.

[201]  C. Burant,et al.  Glucose Transporter Isoforms GLUT1 and GLUT3 Transport Dehydroascorbic Acid* , 1997, The Journal of Biological Chemistry.

[202]  C. Slapak,et al.  Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3. , 1997, British Journal of Cancer.

[203]  M. Sporn.  The war on cancer , 1996, The Lancet.

[204]  H. Scher,et al.  Genistein Is a Natural Inhibitor of Hexose and Dehydroascorbic Acid Transport through the Glucose Transporter, GLUT1 (*) , 1996, The Journal of Biological Chemistry.

[205]  L. Gerweck,et al.  Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.

[206]  M. Sleeman,et al.  Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line. , 1995, Journal of molecular endocrinology.

[207]  I. Ellis,et al.  Oestrogen-regulated genes in breast cancer: association of pLIV1 with lymph node involvement. , 1994, European journal of cancer.

[208]  S. Suster,et al.  Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[209]  T. Jess,et al.  Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors. , 1993, The Biochemical journal.

[210]  J. Vera,et al.  A possible role for a mammalian facilitative hexose transporter in the development of resistance to drugs , 1991, Molecular and cellular biology.

[211]  R. Whitehead.  Colon cancer cells , 1990 .

[212]  P. Lord,et al.  Effects of oestrogen on the expression of a 4.4 kb mRNA in the ZR-75-1 human breast cancer cell line , 1988, Molecular and Cellular Endocrinology.

[213]  R. Weinberg,et al.  The Biology of Cancer , 2006 .